News and breakthroughs in tissue analysis, biomarkers, and pathology technology.
Flagship Biosciences appoints Gina Wallar, Ph.D., MPH as new Chief Commercial Officer
Scientist turned business leader will strengthen the company’s commercial operations and bolster business development efforts. BROOMFIELD, Colo., March 9, 2023 —Flagship Biosciences, Inc., a leader
Flagship Biosciences and Genomenon Partner to Advance Precision Medicine Development
Genomenon’s genomic landscapes enhance Flagship’s biomarker services and companion diagnostic development solutions Broomfield, CO and Ann Arbor, MI – February 7, 2023 – Flagship Biosciences,
Flagship Biosciences hires Tom Turi, Ph.D. as CSO
Accomplished industry executive strengthens company’s position as a leader in spatial biology and biomarker analytics. BROOMFIELD, Colo., September 27, 2022—Flagship Biosciences, Inc., a leader in
Spatial Biology CRO Flagship Biosciences Acquires Pharma Services Business from Interpace Biosciences
Acquisition significantly expands Flagship’s portfolio of biomarker and analytics services BROOMFIELD, Colo., August 31, 2022—Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics
Paige and Flagship Biosciences Announce Partnership to Expand Access to Immuno-Oncology Biomarker Analysis Tools
Partnership to provide access to Flagship’s AI-aided software for quantifying PD-L1 IHC stains across various tissue types NEW YORK and BROOMFIELD, COLO. — February 17,
Flagship Biosciences Listed Among 2022 Colorado Best Small Companies to Work For
Flagship Biosciences Earns Recognition as One of the Best Small Companies to Work For in Colorado January 5, 2022 // Broomfield, CO —Today, Built In
